Herpes simplex virus 1 (HSV-1) encodes an endoribonuclease that is responsible for the shutoff of host protein synthesis [virion host shutoff (VHS)-RNase]. The VHS-RNase released into cells during infection targets differentially four classes of mRNAs. Thus, (a) VHSRNase degrades stable cellular mRNAs and α (immediate early) viral mRNAs; (b) it stabilizes host stress response mRNAs after deadenylation and subsequent cleavage near the adenylate-uridylate (AU)-rich elements; (c) it does not effectively degrade viral β or γ mRNAs; and (d) it selectively spares from degradation a small number of cellular mRNAs. Current evidence suggests that several viral and at least one host protein (tristetraprolin) regulate its activity. Thus, virion protein (VP) 16 and VP22 neutralize the RNase activity at late times after infection. By binding to AU-rich elements via its interaction with tristetraprolin, the RNase deadenylates and cleaves the mRNAs in proximity to the AU-rich elements. In this report we show that another virion protein, U L 47, brought into the cell during infection, attenuates the VHS-RNase activity with respect to stable host and viral α mRNAs and effectively blocks the degradation of β and γ mRNAs, but it has no effect on the processing of AU-rich mRNAs. The properties of U L 47 suggest that it, along with the α protein infected cell protein 27, attenuates degradation of mRNAs by the VHS-RNase through interaction with the enzyme in polyribosomes. Mutants lacking both VHS-RNase and U L 47 overexpress α genes and delay the expression of β and γ genes, suggesting that overexpression of α genes inhibits the downstream expression of early and late genes.
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innate immunity | host response A ttachment and entry of herpes simplex virus 1 (HSV-1) provokes powerful innate immune responses to the virus. HSV-1 blocks the responses in two fundamentally different ways, by bringing into cells at the time of entry both tegument proteins and prepackaged mRNAs and by encoding proteins made immediately after infection with numerous functions designed to block host innate immune responses (1) (2) (3) (4) (5) . Among the best-known and highly effective tegument proteins actively blocking host responses is the virion host shutoff RNase encoded by the U L 41 ORF (6) (7) (8) . This RNase is an endoribonuclease with the specificity of RNase A (9) , and it is active immediately after entry of the virus into cells and during the initial stages of infection. The primary function of VHSRNase appears to be the degradation of mRNAs made in response to infection, but it also prevents, by a mechanism not fully understood, the activation of protein kinase R (10) (11) (12) . At late stages in the viral replicative cycle, virion host shutoff (VHS)-RNase activity is blocked or neutralized by two late proteins, virion protein (VP) 16 and VP22, encoded by U L 48 and U L 49 ORFs, respectively (13, 14) . The RNase cleaves mRNA in polyribosomes (15) . Another partner of the VHS-RNase present in polyribosomes is infected cell protein (ICP) 27, an α (immediate early) multifunctional regulatory protein (16) The VHS-RNase was initially thought to be nonspecific with respect to its target substrate, thus cleaving indiscriminately both viral and cellular mRNAs. More recent studies have shown that this is not the case. Thus, some mRNAs, notably those encoding tristetraprolin and GADD45β are spared, whereas stable host mRNAs are rapidly degraded 5′ to 3′ (2, 17) . One host response to infection is the synthesis of numerous stress response mRNAs carrying adenylate-uridylate (AU)-rich elements (AREs) in their 3′ UTR. In uninfected cells, AREs' mRNAs have a short life of ∼1 h. In cells infected with wild-type virus, those mRNAs are deadenylated and cleaved close to the AREs. Though the 3′ portion is rapidly degraded, the 5′ domain remains stable in the cytoplasm. Finally, recent studies from our laboratory (18) showed that though the VHS-RNase degrades α (immediate early) mRNAs, it essentially spares from degradation β (early) and γ (late) viral mRNAs accumulating during productive infection with wild-type virus.
The degradation of stable host mRNAs has been attributed to the binding of VHS-RNase to the cap structure via its affinity for eIF4H (19, 20) . Studies done to date suggest that VHS-RNase decaps the mRNA, and that the uncapped mRNA is degraded 5′ to 3′ (21, 22) . With respect to the AREs' mRNAs, the available data focused on tristetraprolin, a protein that is induced in infected cells, and whose mRNA is not degraded by VHS. In uninfected cells, tristetraprolin binds AREs and redirects the mRNAs to P bodies or exosomes. Tristetraprolin binds VHS-RNase (23) . One interpretation of the data is that VHS is deflected from the cap structure, binds tristetraprolin at the AREs, and cleaves the mRNA 5′ to the bound enzyme. The cleaved 3′ domain is not protected by a cap and is rapidly degraded. The 5′ domain remains capped and lingers in the cytoplasm for many hours. There are no data to explain the resistance to degradation of viral mRNA in cells infected with wild-type virus.
The hypothesis we chose to pursue is that the VHS-RNase has still another partner responsible for the suppression of degradation of viral mRNAs. In this report we show that VHS-RNase interacts with U L 47, and that U L 47 attenuates the degradation of viral and stable host mRNAs but has no effect on the stability of AREs mRNAs.
Relevant to this report are the following: U L 47 is a 693-residue tegument protein known also as VP13/14 (24) . U L 47 is not essential for virus replication in cell culture (25) . The protein is extensively posttranslationally modified by glycosylation and nucleotidylylations (26, 27) . It has been reported that U L 47 binds
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RNA and shuttles between the cytoplasm and the nucleus (28) . In injunction with ICP27, U L 47 binds and displaces PABC1 from the poly(A) binding protein complex at the cap structure (29) .
Results
Ectopically Expressed U L 47 Is Modified in the Presence of ICP27 and Is Pulled Down by VHS-RNase in the Absence of Other Viral Proteins. In this series of experiments, HEK 293T cells were transfected with plasmids encoding full-length U L 47 tagged with Myc at the N-terminal (U L 47-N-Myc) and/or full-length ICP27. The cells were harvested 48 h after transfection, and total cell lysates were incubated with GST alone or GST fused to full-length VHS (GST-VHS) as previously reported (30) . The electrophoretically separated precipitates were reacted with antibody to the Myc tag. The results shown in Fig. 1 The experimental design of the studies reported here follows that reported earlier (18) . As illustrated schematically in Fig. 3A , replicate cultures of human epidermoid (HEp-2) cells were exposed to 10 pfu of either wild-type parental virus or ΔU L 47 or U L 47-R viruses per cell for 1 h before the inoculum was replaced with fresh medium. After an additional 2 h at 37°C, the cells were exposed to medium containing Actinomycin D (ActD). The cells were harvested and total RNA extracted at the time of ActD addition (time 0) and at 0.5, 1, 3, or 6 h thereafter. The levels of different viral transcripts belonging to the three kinetic classes were analyzed by real-time quantitative PCR (RT-qPCR). The results were normalized with respect to the 18S rRNA and then expressed as fold change compared with the RNA levels present in the cells at the time of ActD addition. The results shown in Fig.  3B were as follows. As expected on the basis of earlier studies (18) , the rates of degradation of α mRNAs (e.g., ICP0, ICP22, and ICP27) were faster than those of β (e.g., ICP8) or γ (VP16 and U L 41) mRNAs. Interestingly, in cells infected by ΔU L 47 mutant virus, the viral mRNAs belonging to the three kinetic classes were degraded faster than those present in wild-type virus-infected cells. Moreover, the rates of degradation of viral mRNA from cells infected with the repaired virus, U L 47-R, could not be differentiated from that observed in cells infected with the wild-type virus.
To validate the results obtained with RT-qPCR, the level of viral RNAs representative of the three kinetic classes (α: ICP0, β: ICP8, and γ: VP16) were also analyzed by Northern blot hybridization ( Fig. 3C ) and quantified by densitometric scanning (Fig. 3D ). The were prepared 48 h after transfection, and reacted with glutathione-agarose beads bound to GST (lanes 4, 6, and 8) or GST-VHS (lanes 5, 7, and 9). The proteins bound to the beads were subjected to electrophoresis on a denaturing polyacrylamide gel, transferred to a nitrocellulose membrane, and reacted with antibody against Myc. Immunoreactivity of U L 47-N-Myc (lanes 1 and 3) from a 1/10th volume of whole-cell lysates is also shown. pcDNA, pcDNA 3.1(+). results clearly indicate that the data obtained by Northern blot analyses mirrored those obtained by RT-qPCR (compare Fig. 3 B with D). Thus, (a) ICP0 mRNA was more rapidly degraded than VP16 or ICP8 mRNAs, (b) the rates of degradation of mRNAs in cells infected with wild-type virus or U L 47-R were similar, and (c) RNA accumulating in cells infected with the ΔU L 47 mutant was degraded more rapidly than those accumulating in cells infected by wild-type virus or repaired virus. The conclusion from this set of data is that U L 47 attenuates the degradation of all classes of viral mRNAs accumulating in cells at 3 h after infection. The experimental design of these studies is shown in Fig. 3A . In brief, HEp-2 cells were exposed to 10 pfu of wild-type HSV-1, ΔU L 47, or U L 47-R viruses per cell for 1 h. The inoculum was replaced with fresh medium and the cells incubated for additional 2 h before ActD was added to the cultures. The cells were harvested at the time of infection (mock), at the time of addition of ActD (time 0), and at 0.5, 1, or 3 h thereafter. Total RNA was extracted and either analyzed by RT-qPCR for β-actin mRNA (Fig. 4A ) or subjected to Northern blot hybridization for GAPDH mRNA accumulation (Fig. 4B) , and the data obtained by densitometric scanning were plotted as fraction of mRNA remaining compared with mock-infected cells (Fig. 4C) . As expected, host mRNA is rapidly degraded during the 3 h after infection. The key finding of Fig. 4 is that U L 47 attenuated the degradation of both stable host mRNAs assayed in this study.
U L 47 Has No Apparent Effect on the Stability of AU-Rich mRNAs
Accumulating After Infection. The design of this experiment is shown in Fig. 5A . Briefly, replicate cultures of HEp-2 cells were exposed to ActD 3 h after infection. The cells were harvested at time of addition of ActD (time 0) and at time intervals shown. Total RNA was subjected to Northern blot analyses. The autoradiographic images of the intact (upper band) RNA shown in Fig.  5B were scanned with the aid of a General Dynamics phosphorimager and normalized with respect to 18S ribosomal RNA and RNA detected at time 0 (Fig. 5C) . The results indicate that U L 47 does not contribute to the stability of the AU-rich RNAs accumulating in infected cells. To assess the contribution of U L 47 to the rates of accumulation of viral mRNAs, it was of interest to construct a mutant lacking both the VHS-RNase and the U L 47 gene. The construction of the double-deletion virus is detailed in Materials and Methods. In the experiments described here, Vero cells were mock infected or exposed to 10 pfu of wild-type HSV-1 or the ΔU L 41/ΔU L 47 mutant virus per cell. The cells were harvested 24 h after infection, and equal amounts of total proteins were electrophoretically separated on a 10% denaturing polyacrylamide gel, transferred to a nitrocellulose sheet, and probed with mouse monoclonal antibody to U S 11 or rabbit polyclonal antibodies to U L 47 and U L 4. As shown in Fig. 6, lane 3 , the double-mutant virus did not express either U L 47 (Fig. 6A) or U L 41 (Fig. 6B) . Both viruses expressed U S 11-a late (γ 2 ) protein (Fig. 6C) . Mutant Virus. The experimental design of these studies is shown schematically in Fig. 7A . Briefly, replicate HEp-2 cell cultures were exposed to 10 pfu of wild-type HSV-1, ΔU L 41, or ΔU L 41/ ΔU L 47 mutant viruses per cell. After 2 h, the inoculum was replaced with fresh medium. The cultures were harvested at the times shown and purified total RNA was analyzed by RT-qPCR. The results were as follows. As shown in Fig. 7B , in the absence of both U L 41 and U L 47, both ICP0 and ICP22 mRNAs, products of α genes, accumulated at a faster rate (Fig. 7B, i and ii) . In cells infected with the double-deletion mutant, the accumulation of ICP8 (an early β) and TK (a late β) mRNAs appeared to be biphasic: there was an initial delay followed by a faster rate of accumulation (Fig. 7B, iii and iv) . A more extensive delay in mRNA accumulation was noted in the case of VP16 and VP22 (both γ genes) mRNAs (Fig. 7B, v and vi) . Although both VP16 and VP22 mRNAs increased in amounts, they lagged behind the mRNA encoded in cells infected with the wild-type virus or the ΔU L 41 mutant. We conclude the following: as predicted from the results shown in Fig. 3 , deletion of both U L 41 and U L 47 increased the rate of accumulation of α mRNAs. Concurrently, as could be predicted, the transition from α to β and γ mRNA synthesis was delayed. Though within the time frame of these studies the accumulation of ICP8 and TK mRNAs ultimately reached the levels of mRNAs accumulating in wild-type virus-infected cells, the levels of the γ mRNAs encoded by VP16 and VP22 genes continued to lag behind those of wild-type virus.
The differences in the accumulation of mRNAs encoded by wild-type and ΔU L 41 viruses did not differ significantly or differed less extensively than those between the wild-type and ΔU L 41/ ΔU L 47 mutant viruses. These results mirror the results reported previously (31) , suggesting that the rate of transition from α to β to γ genes expression in wild-type virus-infected cells is largely enabled by U L 47.
Discussion
The salient features of the results presented here are as follows: (i) U L 47, a tegument protein made late in infection, is modified in transfected cells in the presence of ICP27 and interacts with U L 41 in the absence of other viral proteins. (ii) U L 47 attenuates the degradation of all kinetic classes of viral mRNAs. (iii) U L 47 attenuates the degradation of stable host mRNA in infected cells but has no apparent effect on the stability of the AREs-mRNAs induced in infected cells. (iv) The transition from α to β and γ genes' mRNA synthesis is significantly delayed in the absence of U L 47. The significance of these findings is as follows:
VP16 was the first viral protein shown to interact with VHS and, in the context of infected cells, shown to abrogate the RNase activity (13) . The demonstration that neutralization of VHS activity required VP22 emerged from the observation that deletion of the gene encoding VP22 resulted in the selection of mutants defective in RNase activity (32) . The evidence that VHS-RNase interacts with ICP27 emerged from studies designed to determine the role of this α protein in the degradation of viral mRNAs (33) . We selected U L 47 to study its role as a potential partner of VHS-RNase on the basis of the evidence that VHS-RNase degrades mRNAs in polyribosomes and the report that U L 47 binds the poly(A) binding protein (29) . The striking feature of the results obtained so far is that three of the four known viral partners of VHS-RNase are tegument proteins, and that the function of all three is to attenuate or neutralize the RNase activity of VHS. One hypothesis that could explain the wealth of proteins that regulate the VHS-RNase activity is that they function at different times during the replicative cycle or in different environments. For example, the RNase- neutralizing activities of VP16 and VP22 could be confined to a late stage in the replicative cycle rather than to the proteins packaged and brought into the newly infected cells. This conclusion is consistent with the evidence that VHS is active following infection, even though all three proteins are brought into the newly infected cell. In contrast, the VHS-RNase-attenuating activities of U L 47 and those associated with ICP27 could be expressed in polyribosomes assembled after the entry of the virus into cells.
A preceding report from this laboratory demonstrated that with the possible exception of α mRNAs, viral RNAs are relatively resistant to degradation attributed to VHS-RNase (18) . The results presented here indicate that U L 47 attenuates the degradation of all kinetic classes of viral mRNAs and hence it most likely acts on VHS-RNase rather than on specific features of viral mRNAs. In the absence of both VHS-RNase and U L 47 gene, α mRNAs accumulate at a faster rate, whereas the accumulation of β and γ mRNAs is delayed. Additional evidence supporting the hypothesis that α mRNA accumulations are tightly controlled is the observation that ICP4 inhibits its own transcription by binding to its transcription initiation site (34, 35) . The hypothesis that α mRNAs outcompete viral mRNAs with respect to efficiency of synthesis or translation is tempered by the observation that HSV also controls the accumulation and function of key α proteins. Thus, (a) at early time after infection ICP0, a key regulatory protein turns over with a half-life of less than 1 h. Between 6 and 9 h after infection the nucleus is totally depleted of ICP0 (36) . (b) The product of ORF O, a protein made late in infection, blocks the function of ICP4 (37) . It is conceivable that the relatively rapid turnover of α mRNAs compared with β or γ mRNAs is a component of the design to tightly control the synthesis and accumulation of α proteins and that, by default, overexpression of α proteins is detrimental to the orderly transition from α to β and γ protein synthesis.
Assuming that the U L 47 interacts randomly with the VHS-RNase in infected cells, as suggested by the observation that it attenuates the degradation of all classes of mRNAs, it is not surprising that it also attenuates the degradation of host mRNAs after infection. Two observations, however, are worthy of note. First, the pattern of degradation of stable cellular mRNAs appears to be similar to that of viral α mRNAs rather than that of β or γ mRNAs. We have no evidence to support the hypothesis that host and viral α mRNAs share features that differentiate them from β or γ mRNAs. A more likely scenario is that an α protein, possibly ICP27, plays a role in enhancing the stability of viral mRNAs made later in infection. ICP27 has been reported to enhance the translation of γ mRNAs (38) , but the effect may be due to stabilization of the mRNAs rather than to a specific effect on the translational machinery of the infected cell. It is noteworthy, as shown in this report, that ICP27 mediates a posttranslational modification as well as enhancement of accumulation of U L 47 in cotransfected cells (Fig. 1) .
The second noteworthy observation is that U L 47 has no effect on the pattern of accumulation of AREs-mRNAs. One hypothesis that could explain this observation is based on the evidence that (a) VHS-RNase binds tristetraprolin, which in turn binds to the AREs, and (b) VHS-RNase performs two functions: it deadenylates the mRNA and cleaves the mRNA at or near AREs. It is conceivable that U L 47 does not affect or participate in the interactions of VHS-RNase with tristetraprolin and the AREs.
The sum total of the available data on the function of VHSRNase may be viewed from the prospective of the function of VHS-RNase in the viral replicative cycle. Specifically, the data suggest that VHS-RNase is a non-target-specific endoribonuclease that is tightly regulated to degrade only specific targets. The regulators identified to date are VP16, VP22, U L 47, and ICP27. The net effects of the carefully orchestrated regulation are to degrade two groups of mRNAs and spare a third. One group, degraded schematically as illustrated in Fig. 8A , consists of stable host and viral α mRNAs. The objective, as discussed above, is perhaps to control the synthesis and accumulation of α gene products and enable efficient transition from α to β and γ genes' expression. The second group targeted by the VHS-RNase in a manner schematically depicted in Fig. 8B contains stress-response mRNAs that reflect, in large part, host innate responses. The group that is spared, as illustrated schematically in Fig. 8C , consists of viral mRNAs that encode proteins required for viral DNA synthesis and structural proteins. It would make little sense to degrade the mRNAs directing the synthesis of these proteins.
Materials and Methods
Cells and Viruses. HEp-2, Vero, and HEK 293T cell lines were obtained from the American Type Culture Collection. All cell lines were grown in Dulbecco's modified Eagle medium supplemented with 5% (vol/vol) FCS (HEp-2 cells), 5% (vol/vol) newborn calf serum (Vero cells), or 10% (vol/vol) FBS (HEK 293T cells). The BAC encoding the HSV-1(F) DNA was reported elsewhere (39, 40) .
Antibodies. The rabbit polyclonal antibody against U L 41 has been described elsewhere (30) . Rabbit polyclonal antibody against U L 47 was kindly provided by D. M. Meredith (Leeds University, Leeds, United Kingdom). Mouse monoclonal antibody against actin and Myc tag were purchased from Sigma and Santa Cruz Biotechnology, respectively. All of the antibodies were used in a dilution of 1:1,000.
Plasmids. The full length of U L 47 tagged with Myc at the 5′ end and ICP27 ORF was subcloned into pcDNA 3.1(+) transfer vector from previously generated constructs (30) . The resulting plasmids were named pU L 47 and pICP27, respectively. HEK 293T Cell Transient Transfection. The procedures for transfection HEK 293T cells were described previously (14) . The cells were harvested 48 h after transfection and lysed according to the protocol for the subsequent GST pull-down assay.
GST Pull-Down Assay. The procedures of pull-down were performed as previously described (14) . Briefly, transfected HEK 293T cells were lysed in GST lysis buffer [20 mM Tris (pH 8.0)/1 mM EDTA/1% Nonidet P-40/200 mM NaCl/ 0.1 mM sodium orthovanadate/10 mM NaF/2 mM DTT/protease inhibitor mixture (Complete Protease; Roche Diagnostics] on ice for 1 h. Insoluble material was pelleted by centrifugation at maximum speed in a 5415C centrifuge (Eppendorf) for 10 min at 4°C. The supernatant fluids precleared with 50 μL of a 50% slurry of glutathione beads for 3 h at 4°C were incubated overnight at 4°C with equal amounts of a 50% slurry of glutathione beads bound to GST alone or GST fused to the VHS protein. The beads were pelleted by centrifugation and rinsed five times with GST buffer. The proteins bound to the beads were solubilized in 50 μL of SDS gel-loading buffer [2% SDS/5% 2-mercaptoethanol/50 mM Tris (pH 6.8)/2.75% sucrose), heated to 95°C for 5 min, resolved by PAGE, transferred to nitrocellulose membrane, and immunoblotted with the mouse anti-Myc antibody.
Immunoblot Analysis. Cells were collected 24 h after infection. The procedures for harvesting, solubilization, protein quantification, SDS/PAGE, and transfer to nitrocellulose membranes were performed as previously reported (41) . The membrane was probed for U L 47, U L 41, Myc tag, and β-actin with the antibodies listed above.
Construction of Recombinant Viruses. The construction procedures were described previously (42) . Briefly, The U L 41 ORF is contained in two different HSV-1 BamHI fragments, BamHI(0), and BamHI(I), and the U L 47 ORF is contained in HSV-1 BamHI(F) fragment (43) . The pRB129 containing BamHI(O) was digested with HindIII and BamHI. The pRB130 containing BamHI(I) fragment was digested with SacI and BamHI. The 1.5-kb HindIII-BamHI fragment from BamHI(O), along with the 2.0-kb SacI-BamHI fragment, was cloned in pUC19 to generate pRB9001. The pRB9001 was subsequently digested with HindIII and EcoRI. The 3.6-kb HindIII-EcoRI fragment from pRB9001 was subcloned in pBlueScript KS(+) to generate pRB9002. The pRB9002 was then digested with BmgBI and self-ligated to eliminate 822 bp within the U L 41 ORF; this generated pRB9003, which contains ΔU L 41 ORF plus flanking sequences. The pRB9003 was then digested with XhoI and XbaI, and the 2.8-kb fragment containing ΔU L 41 ORF plus flanking sequences was cloned into a pKO5 plasmid (44) to generate pKO9003. The 1.2-kb upstream flanking sequence of U L 47 was amplified from pRB128 by PCR using the primers U L 47-up-F (5′-CGG GAT CCG GTG GCG ATA GAC GCG GGT TAT CGG ATG -3′) and U L 47-up-R (5′-TGC TCT AGA AGG TAC TAC CGA GAG ACC GCT CGT CTG -3′), which contain a BamHI and a XbaI restriction size, respectively. The 1.2-kb fragment was cloned in pBlueScript KS(+) to generate pRB9004. The 1.3-kb downstream flanking sequence of U L 47 was amplified from pRB128 by PCR using the primers U L 47-down-F (5′-CGG AAT TCA AGC TCC TCC CGA TAA AAA GCG CCC-3′) and U L 47-down-R (5′-CCG CTC GAG CCC GAA CCA AGC CTT GAT GCT CAA C-3′), which contain an EcoRI and a XboI restriction size, respectively. The 1.3-kb fragment was subcloned into pRB9004 to generate pRB9005, which contains up-and downstream flanking sequences of U L 47. The pRB9005 was then digested with XhoI and XbaI, and the 2.5-kb fragment containing U L 47 flanking sequences was cloned into pKO5 plasmid to generate pKO9005. The U L 47 coding sequence tagged with Myc in the 3′ end was amplified from pRB128 by PCR using the primers U L 47-myc-F (5′-CCG GAA TTC TTA CAG ATC  TTC TTC AGA AAT AAG TTT TTG TTC TGG GCG TGG CGG GCC TCC CAG CCC-3′) and U L 47-myc-R (5′-CGC GGA TCC ATG TCG GCT CGC GAA CCC GCG GGG-3′), which contain a EcoRI and Myc tag sequence and a BamHI restriction size, respectively. The fragment of Myc-tagged U L 47 coding sequence was cloned into pRB9005 to generate pRB9006. The pRB9006 was then digested with XhoI and XbaI, and the 4.5-kb fragment containing Myc-tagged U L 47 ORF plus flanking sequences was cloned into a pKO5 plasmid to generate pKO9006. Escherichia coli RR1 stain harboring HSV-1 BAC was electroporated with pKO9003, pKO9005, and pKO9006, respectively, and incubated at 43°C on LB Fig. 8 . A model of the role of U L 47 on VHS-dependent mRNA degradation. Current models of actively translated mRNAs display that they are maintained in a closed-loop conformation by the interaction of the translation initiation complex eIF4F bound to the 5′ cap with the poly(A)-binding protein (PABP) at the 3′ end of RNA. (A) For stable host and α viral mRNAs, VHS-RNase bound to eIF4H, a component of the eIF4F complex, decaps the mRNA, thus initiating the degradation of mRNA by the 5′ exonuclease Xrn1. However, this process could be attenuated by U L 47 bound to VHS. (B) For stress-response mRNAs, VHS-RNase binds preferentially to tristetraprolin (TTP) and cleaves the ARE-mRNA 5′ to the AREs. The product of cleavage inside the 3′ UTR is equivalent to a deadenylated mRNA accessible to the multimeric complex of 3′ to 5′ exonucleases known as the exosome. (C) For β and γ viral mRNAs, studies in this report suggest that U L 47 bound to VHS, which also can interact with ICP27, probably interferes with the decapping of the mRNA and consequently the degradation of mRNA by the 5′ exonuclease Xrn1.
